These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1517355)

  • 1. Hyperprolactinemia and osteopenia.
    Wardlaw SL; Bilezikian JP
    J Clin Endocrinol Metab; 1992 Sep; 75(3):690-1. PubMed ID: 1517355
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea.
    Biller BM; Baum HB; Rosenthal DI; Saxe VC; Charpie PM; Klibanski A
    J Clin Endocrinol Metab; 1992 Sep; 75(3):692-7. PubMed ID: 1517356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone tissue in patients with hyperprolactinemic hypogonadism].
    Rozhinskaia LIa; Marova EI; Dzeranova LK; Rassokhin BM; Purtova GS; Goncharov NP; Mishchenko BP; Ilovaĭskaia IA
    Probl Endokrinol (Mosk); 1992; 38(6):17-9. PubMed ID: 1302840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of severe osteopenia in a patient with hyperprolactinemia treated with bromocriptine.
    Lindberg JS; Kolb FO; Blau RA; Powell MR
    West J Med; 1988 Sep; 149(3):341-3. PubMed ID: 3176495
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperprolactinemia and hypogonadism.
    Vaidya RA
    J Assoc Physicians India; 1993 Nov; 41(11):700-1. PubMed ID: 8005920
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase in bone mass after treatment of hyperprolactinemic amenorrhea.
    Klibanski A; Greenspan SL
    N Engl J Med; 1986 Aug; 315(9):542-6. PubMed ID: 3736637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteopenia in beta-thalassemia major].
    Brändle M; Galeazzi RL; Morant R; Oesterle M
    Schweiz Med Wochenschr; 1996 Nov; 126(44):1867-74. PubMed ID: 8984599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia.
    Schlechte J; Walkner L; Kathol M
    J Clin Endocrinol Metab; 1992 Sep; 75(3):698-703. PubMed ID: 1517357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolactin and estrogen deficiency in amenorrheic bone loss.
    Klibanski A; Biller BM; Rosenthal DI; Schoenfeld DA; Saxe V
    J Clin Endocrinol Metab; 1988 Jul; 67(1):124-30. PubMed ID: 3379129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin.
    Zadrozna-Sliwka B; Bolanowski M; Jawiarczyk A; Kaluzny M; Syrycka J
    Neuro Endocrinol Lett; 2008 Feb; 29(1):178-84. PubMed ID: 18283239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopenia in primary and secondary amenorrhea.
    Ulrich U; Pfeifer T; Buck G; Lauritzen C
    Horm Metab Res; 1995 Sep; 27(9):432-5. PubMed ID: 8557244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HETEROGENEITY OF CLINICAL MANIFESTATIONS OF HYPERPROLACTINEMIA (REVIEW AND OWN OBSERVATIONS).
    Barabash N; Tykhonova T; Dorosh D; Martymianova L
    Georgian Med News; 2022 Sep; (330):32-36. PubMed ID: 36427837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.
    Andereggen L; Frey J; Andres RH; Luedi MM; Widmer HR; Beck J; Mariani L; Christ E
    Sci Rep; 2021 Mar; 11(1):5122. PubMed ID: 33664388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia/Osteoporosis.
    Yun SJ; Sang H; Park SY; Chin SO
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism.
    Greenspan SL; Oppenheim DS; Klibanski A
    Ann Intern Med; 1989 Apr; 110(7):526-31. PubMed ID: 2923387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and magnitude of osteopenia in patients with prolactinoma.
    Kayath MJ; Lengyel AM; Vieira JG
    Braz J Med Biol Res; 1993 Sep; 26(9):933-41. PubMed ID: 8298528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.
    Di Somma C; Colao A; Di Sarno A; Klain M; Landi ML; Facciolli G; Pivonello R; Panza N; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1998 Mar; 83(3):807-13. PubMed ID: 9506732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypothalamic hypogonadism].
    Tasaka K; Tahara M; Ogata S; Nishimoto F
    Nihon Rinsho; 2006 Jun; Suppl 2():335-9. PubMed ID: 16817416
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteopenia in women with hypothalamic amenorrhea: a prospective study.
    Biller BM; Coughlin JF; Saxe V; Schoenfeld D; Spratt DI; Klibanski A
    Obstet Gynecol; 1991 Dec; 78(6):996-1001. PubMed ID: 1945230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperprolactinaemia and bone mineral density].
    Kostrzak A; Męczekalski B
    Pol Merkur Lekarski; 2015 Aug; 39(230):122-5. PubMed ID: 26319389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.